|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Identification and characterization of nine polymorphic microsatellite loci in the North American pika,Ochotona princes显示文摘 | Veronica S Kirchoff and Susan J Merideth | 2002 | Molecukar Ecology Notes2002，11，2： | 1 |
| 2 | Outcomes associated with a structured prenatal counseling program for shoulder dystocia with brachial plexus injury显示文摘 | Mary Veronica Daly Christina Bender Kathryn E. Townsend Emily F. Hamilton | 2012 | American Journal of Obstetrics and Gynecology2012，，2： | 1 |
| 3 | The value of platinum agents as neoadjuvant chemotherapy in triple-negative breast cancers: a systematic review and meta-analysis显示文摘 | Fausto Petrelli Andrea Coinu Karen Borgonovo Mary Cabiddu Mara Ghilardi Veronica Lonati Sandro Barni | 2014 | Breast Cancer Research and Treatment2014，，2： | 1 |
| 4 | FOLFIRI-Bevacizumab As First-Line Chemotherapy in 3500 Patients With Advanced Colorectal Cancer: A Pooled Analysis of 29 Published Trials显示文摘 | Fausto Petrelli Karen Borgonovo Mary Cabiddu Mara Ghilardi Veronica Lonati Federica Maspero Maria Grazia Sauta Giordano Domenico Beretta Sandro Barni | 2013 | Clinical Colorectal Cancer2013，，： | 1 |
| 5 | Fibrinogen and left ventricular myocardial systolic function: The Multi-Ethnic Study of Atherosclerosis (MESA)显示文摘 | Raymond T. Yan Veronica Fernandes Andrew T. Yan Mary Cushman Alban Redheuil Russell Tracy Jens Vogel-Claussen Hossein Bahrami Khurram Nasir David A. Bluemke Joao A.C. Lima | 2010 | American Heart Journal2010，，3： | 1 |
| 6 | The International Baccalaureate Diploma and Student Attitudes: An Exploratory Study显示文摘 | Veronica Wilkinson Mary Hayden | 2010 | Journal of Research in International Edu- cation2010，9，1： | 1 |
| 7 | How Jamaica Kincaid writes the autobiogra- phy of her mother显示文摘 | Gregg Veronica Marie | 2002 | Callaloo2002，25，3： | 1 |
| 8 | Which strategy after first-line therapy in advanced colorectal cancer?显示文摘Second-line therapy for advanced colorectal cancer is an integral part of the treatment strategy that needs to be set from the beginning for each patient, bearing in mind the expected toxicities of chosen treatments, the patient's clinical condition, comorbidities, preferences, the aims of the treatment and the molecular status. Furthermore, the distinction between lines of therapy is no longer absolute. The perspective of 'continuum of care' includes switching chemotherapy prior to disease progression, maintenance therapy, drug 'holidays' if needed, surgical resection of metastases in selected patients, and seems to allow a tailored treatment, in which patients are more likely to benefit from exposure to all active agents, which is known to correlate with overall survival. The scenario of second-line treatment has changed dramatically over the years and could currently benefit from several options including chemotherapy with a single agent or in combination and the addition of molecular-targeted agents developed in the last decade, such as epidermal growth factor receptor antibodies(cetuximab, panitumumab) and vascular endothelial growth factor-targeting agents(bevacizumab, aflibercept), with the possibility of bevacizumab use even beyond first progression. The purpose of this review is to summarize the most important scientific data supporting the use of chemotherapy and the new biologic agents in the second-line setting in advanced colorectal cancer. | Coinu Andrea Petrelli Fausto Borgonovo Karen Francesca Cabiddu Mary Ghilardi Mara Lonati Veronica Barni Sandro | 2014 | World Journal of Gastroenterology2014，20，27： | 1 |
| 9 | The control of soil-transmitted helminthiases in the Philippines: the story continues显示文摘Background:Soil-transmitted helminth(STH)infections have long been an important public health concern in the Philippines.In this review,we describe the current status of STH infections there and highlight the control efforts undertaken to reduce STH burden.Main text:A nationwide STH mass drug administration(MDA)programme was started in 2006 but the overall STH prevalence remains stubbornly high across the Philippines,rangi ng from 24.9%to 97.4%. | Mary Lorraine S.Mationg Veronica L.Tallo Gail M.Williams Catherine A.Gordon Archie C.A.Clements Donald P.McManus Darren J.Gray | 2021 | Infectious Diseases of Poverty2021，10，3： | 0 |
| 10 | Impact of COVID-19 on presentation,management,and outcomes of acute care surgery for gallbladder disease and acute appendicitis显示文摘BACKGROUND The ongoing coronavirus disease 2019(COVID-19)pandemic has significantly disrupted both elective and acute medical care.Data from the early months suggest that acute care patient populations deferred presenting to the emergency department(ED),portending more severe disease at the time of presentation.Additionally,care for this patient population trended towards initial non-operative management.AIM To examine the presentation,management,and outcomes of patients who developed gallbladder disease or appendicitis during the pandemic.METHODS A retrospective chart review of patients diagnosed with acute cholecystitis,symptomatic cholelithiasis,or appendicitis in two EDs affiliated with a single tertiary academic medical center in Northern California between March and June,2020 and in the same months of 2019.Patients were selected through a research repository using international classification of diseases(ICD)-9 and ICD-10 codes.Across both years,313 patients were identified with either type of gallbladder disease,while 361 patients were identified with acute appendicitis.The primary outcome was overall incidence of disease.Secondary outcomes included presentation,management,complications,and 30-d re-presentation rates.Relationships between different variables were explored using Pearson’s r correlation coefficient.Variables were compared using the Welch’s t-Test,Chi-squared tests,and Fisher’s exact test as appropriate.RESULTS Patients with gallbladder disease and appendicitis both had more severe presentations in 2020.With respect to gallbladder disease,more patients in the COVID-19 cohort presented with acute cholecystitis compared to the control cohort[50%(80)vs 35%(53);P=0.01].Patients also presented with more severe cholecystitis in 2020 as indicated by higher mean Tokyo Criteria Scores[mean(SD)1.39(0.56)vs 1.16(0.44);P=0.02].With respect to appendicitis,more patients were diagnosed with a perforated appendix at presentation in 2020[20%(36)vs 16%(29);P=0.02]and a greater percentage were classified as emergent cases using the emergency severity index[63%(112)vs 13%(23);P<0.001].While a greater percentage of patients were admitted to the hospital for gallbladder disease in 2020[65%(104)vs 50%(76);P=0.02],no significant differences were observed in hospital admissions for patients with appendicitis.No significant differences were observed in length of hospital stay or operative rate for either group.However,for patients with appendicitis,30-d re-presentation rates were significantly higher in 2020[13%(23)vs 4%(8);P=0.01].CONCLUSION During the COVID-19 pandemic,patients presented with more severe gallbladder disease and appendicitis.These findings suggest that the pandemic has affected patients with acute surgical conditions. | Orly Nadell Farber Giselle I Gomez Ashley L Titan Andrea T Fisher Christopher J Puntasecca Veronica Toro Arana Arielle Kempinsky Clare E Wise Kovi E Bessoff Mary T Hawn James R Korndorffer Jr Joseph D Forrester Micaela M Esquivel | 2021 | World Journal of Gastrointestinal Surgery2021，13，8： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员